Lipid nanoparticles for drug targeting to the brain

Methods in Enzymology

Volumn 508, Issue , 2012, Pages 229-251

  Bondì, Maria Luisa ^a   Di Gesù, Roberto ^b   Craparo, Emanuela Fabiola ^b  

^a CNR   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Brain diseases; Characterization; Drug loading; Drug targeting; Lipid nanocarriers; Production methods

Indexed keywords

ATAZANAVIR; CAMPTOTHECIN; CURCUMIN; DIMINAZENE; FERULIC ACID; NANOCARRIER; RILUZOLE; SOLID LIPID NANOPARTICLE;

ALLERGIC ENCEPHALOMYELITIS; BLOOD BRAIN BARRIER; BRAIN DISEASE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MECHANISM; DRUG STABILITY; DRUG STORAGE; DRUG TARGETING; ENDOCYTOSIS; FREEZE DRYING; HUMAN; LIPOPHILICITY; NANOPHARMACEUTICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; REVIEW; SCALE UP; SUSTAINED DRUG RELEASE; TREATMENT INDICATION;

EID: 84859022129     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-391860-4.00012-4     Document Type: Chapter

References (85)

1. N.J. Abbott Evidence for bulk flow of brain interstitial fluid: Significance for physiology and pathology Neurochem. Int. 45 2004 545 552 (Pubitemid 38739482)
2. N.J. Abbott, L. Rönnbäck, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nat. Rev. Neurosci. 7 2006 41 53 (Pubitemid 41828930)
3. Y. Aktas, M. Yemisci, K. Andrieux, R.N. Gursoy, M.J. Alonso, E. Fernandez-Megia, R. Novoa-Carballal, E. Quiñoa, R. iguera, M.F. Sargon, H.H. Celik, and A.S. Demir Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26 Bioconjug. Chem. 16 2005 1503 1511 (Pubitemid 41681517)
4. M.A. Badruddoja, and K.L. Black Improving the delivery of therapeutic agents to CNS neoplasms: A clinical review Front. Biosci. 11 2006 1466 1478 (Pubitemid 43253434)
5. D.J. Begley The blood-brain barrier: Principles for targeting peptides and drugs to the central nervous system Proc. Natl. Acad. Sci. USA 48 1996 136 146 (Pubitemid 26129083)
6. D. Begley Efflux mechanisms in the central nervous system: A powerful influence on drug distribution within the brain W.J. Sharma, Spinal Cord and Brain Barriers in Health and Disease 2003 83 97
7. D.J. Begley Delivery of therapeutic agents to the central nervous system: The problems and the possibilities Pharmacol. Ther. 104 2004 29 45 (Pubitemid 39410561)
8. J.E. Bell, I.C. Anthony, and P. Simmonds Impact of HIV on regional and cellular organisation of the brain Curr. HIV Res. 4 2006 249 257 (Pubitemid 44027715)
9. P. Blasi, S. Giovangioli, A. Schoubben, M. Ricci, and C. Rossi Solid lipid nanoparticles for targeted brain drug delivery Adv. Drug Deliv. Rev. 59 2007 454 477 (Pubitemid 47259226)
10. M.L. Bondì, E.F. Craparo, G. Giammona, and F. Drago 2008 Vol. WO2008/000448 A2
11. M.L. Bondì, G. Montana, E.F. Craparo, P. Picone, G. Capuano, G. Di Carlo, and G. Giammona Ferulic acid-loaded lipid nanostructures as drug delivery systems for Alzheimer's disease: Preparation, characterization and cytotoxicity studies Curr. Nanosci. 5 2009 26 32
12. M.L. Bondì, E.F. Craparo, G. Giammona, and F. Drago Brain-targeted solid lipid nanoparticles containing riluzole: Preparation, characterisation and biodistribution Nanomedicine 5 2010 25 32
13. M.L. Bondì, E.F. Craparo, P. Picone, M. Di Carlo, R. Di Gesù, G. Capuano, and G. Giammona Curcumin entrapped into lipid nanosystems inhibits neuroblastoma cancer cell growth and activate Hsp70 protein Curr. Nanosci. 6 2010 439 445
14. N. Butowski, and S.M. Chang Small molecule and monoclonal antibody therapies in neurooncology Cancer Control 12 2005 116 124 (Pubitemid 40647055)
15. J.D. Byrne, T. Betancourt, and L. Brannon-Peppas Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Deliv. Rev. 60 2008 1615 1626
16. R. Cecchell, V. Berezowski, S. Lundquis, M. Culot, M. Renftel, M.P. Dehouck, and L. Fenart Modelling of the blood-brain barrier in drug discovery and development Nat. Rev. Drug Discov. 6 2007 650 661 (Pubitemid 47202487)
17. N. Chattopadhyay, J. Zastre, H.L. Wong, X.Y. Wu, and R. Bendayan Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line Pharm. Res. 25 2008 2262 2271
18. D. Chen, T. Yang, W. Liang, and Q. Zhang In vitro and in vivo study of two types of long circulating solid lipid nanoparticles containing Paclitaxel Chem. Pharm. Bull. 49 2001 1444 1447 (Pubitemid 33043274)
19. E.F. Craparo, M.L. Bondì, G. Pitarresi, and G. Cavallaro Nanoparticulate systems for drug delivery and targeting to the central nervous system CNS Neurosci. Ther. 17 2011 670 677
20. A. Croquelois, G. Assal, J.M. Annoni, F. Staub, A. Gronchi, L. Bruggimann, S. Dieguez, and J. Bogousslavsky Diseases of the nervous system: Patients' aetiological beliefs J. Neurol. Neurosurg. Psychiatry 76 2007 582 584
21. B. Dehouck, C. Fenart, M.-P. Dehouck, A. Pierce, G. Torpier, and R.A. Cechelli A new function for then LDL receptor: Transcytosis of LDL across the blood brain barrier J. Cell Biol. 138 1997 887 889
22. N. Denora, A. Trapani, V. Laquintana, A. Lopedota, and G. Trapani Recent advances in medicinal chemistry and pharmaceutical technology-strategies for drug delivery to the brain Curr. Top. Med. Chem. 9 2009 182 196
23. M.A. Fernandez, M.T. Saenz, and M.D. Garcia Anti-inflammatory activity in rats and mice of phenolic acids isolated from Scrophularia frutescens J. Pharm. Pharmacol. 50 1998 1183 1186 (Pubitemid 28488140)
24. A. Fundaro, R. Cavalli, A. Bagoni, D. Vighetto, G.P. Zara, and M.R. Gasco Non-stealth and stealth solid lipid nanoparticles(sln) carrying doxorubicin: Pharmacokinetic and tissue distribution after i.v. administration to rats Pharm. Res. 42 2000 337 343
25. R. Gabathuler Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases Neurobiol. Dis. 37 2010 48 57
26. P.J. Gaillard, C.C. Visser, and A.G. de Boer Targeted delivery across the blood-brain barrier Expert Opin. Drug Deliv. 12 2005 299 309 (Pubitemid 41130884)
27. E. Garcia-Garcia, K. Andrieux, S. Gil, and P. Couvreur Colloidal carriers and blood-brain barrier (BBB) translocation: A way to deliver drugs to the brain? Int. J. Pharm. 298 2005 274 292 (Pubitemid 40910731)
28. G. Ghersi, M. Egea, and Y. Sugiyama transfer in the choroid plexus. Multiplicity and substrate specificities of transporters Adv. Drug Deliv. Rev. 56 2004 1693 1694 (Pubitemid 39286156)
29. B.C. Giovanella, S. Stchlin, M.E. Wall, M.C. Wani, A.W. Nicholas, L.F. Liu, R. Silber, and M. Potmesil DNA topoisomerase I targeted chemotherapy of human colon cancer in xenografts Science 246 1989 1046 1048 (Pubitemid 20010531)
30. B.C. Giovanella, R. Hinz, A. Kozielski, L.S. Slehlin Jr., R. Silber, and M. Pormesil Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)- camptothecin Cancer Res. 51 1991 3052 3055
31. Y. Gong, B. Robinson, R. Rose, C. Deminie, T. Spicer, and M. Markowitz Antiviral activity and resistance profile of an HIV-1 protease inhibitor BMS-232632 38th Interscience Conference on Antimicrobial Agents and Chemotherapy 1999
32. T.M. Göppert, and R.H. Müller Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns J. Drug Target. 13 2005 179 187 (Pubitemid 40668171)
33. J. Gualbert, P. Shahgaldian, and A.W. Coleman Interactions of amphiphilic calyx[4]arene-based solid lipid nanoparticles with bovine serum albumin Int. J. Pharm. 257 2003 69 73 (Pubitemid 36507033)
34. C. Guerin, A. Olivi, J.D. Weingart, H.C. Lawson, and H. Brem Recent advances in brain tumor therapy: Local intracerebral drug delivery by polymers Invest. New Drugs 22 2004 27 37 (Pubitemid 38196980)
35. B.T. Hawkins, and T.P. Davis The blood-brain barrier/neurovascular unit in health and disease Pharmacol. Rev. 57 2005 173 185 (Pubitemid 41043883)
36. R.A. Hawkins, R.L. O'Kane, I.A. Simpson, and J.R. Viñaz Branched-chain amino acids: Metabolism, physiological function, and application J. Nutr. 136 2006 218 226
37. Y. Hu, J. Xie, T.Y. Wah, and C.H. Wang Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells J. Control. Release 118 2007 7 17 (Pubitemid 46283099)
38. K.K. Jain Nanotechnology-based drug delivery for cancer Technol. Cancer Res. Treat. 4 2005 407 416 (Pubitemid 41242614)
39. C.E. Johanson, J.A. Duncan, E.G. Stopa, and A. Baird Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route Pharm. Res. 22 2005 1011 1037 (Pubitemid 41130789)
40. M.D. Joshi, and R.H. Müller Lipid nanoparticles for parenteral delivery of actives Eur. J. Pharm. Biopharm. 71 2009 161 172
41. L. Juillerat-Jeanneret The targeted delivery of cancer drugs across the blood-brain barrier: Chemical modifications of drugs or drug-nanoparticles? Drug Discov. Today 13 2008 1099 1106
42. J. Kanski, M. Aksenova, A. Stoyanova, and D.A. Butterfield Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: Structure-activity studies J. Nutr. Biochem. 13 2002 273 281 (Pubitemid 34556688)
43. M. Kaul, and S.A. Lipton Mechanisms of neuronal injury and death in HIV-1 associated dementia Curr. HIV Res. 4 2006 307 318 (Pubitemid 44027720)
44. I.P. Kaur, R. Bhandari, and S. Bhandari Potential of solid lipid nanoparticles in brain targeting J. Control. Release 127 2008 97 109
45. H. Kikuzaki, M. Hisamoto, K. Hirose, K. Akiyama, and H. Taniguchi Antioxidant properties of ferulic acid and its related compounds J. Agric. Food Chem. 50 2002 2161 2168 (Pubitemid 34260027)
46. H. Komatsu, A. Kitajima, and S. Okada Pharmaceutical characterization of commercially available intravenous fat emulsions: Estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy Chem. Pharm. Bull. 43 1995 1412 1415
47. J.M. Koziara, P.R. Lockman, D.D. Allen, and R.J. Mumper In situ blood-brain barrier transport of nanoparticles Pharm. Res. 20 2003 1772 1778 (Pubitemid 37449450)
48. J.M. Koziara, R.J. Mumper, J.J. Oh, W.S. Akers, and S.P. Ferraris Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles Pharm. Res. 22 2005 1821 1828 (Pubitemid 41504335)
49. J. Kreuter, and R.N. Alyautdin Using nanoparticles to target drugs to the central nervous system M.W. Bradbury, D.J. Begley, J. Kreuter, The Blood Brain Barrier and Drug Delivery to the CNS 2000 Marcel Dekker New York 205 223
50. R.N. Lawrence Sir Richard Sykes contemplates the future of the pharma industry Drug Discov. Today 7 2002 645 648
51. R.M. Levy, and D.E. Bredesen Central nervous system dysfunction in acquired immunodeficiency syndrome M.L. Rosenblum, R.M. Levy, AIDS and The Nervous System Vol. 1 1988 27 64
52. J.P. Lon, and A.E. Ahmed Determination of camptothecin in biological fluids using reversed phase high-performance liquid chromatography with fluorescence detection J. Chromatogr. Biomed. Appl. 530 1990 367 376 (Pubitemid 20276124)
53. U. Lungwitz, M. Breunig, T. Blunk, and A. Gopferich Polyethyleniminebased non-viral gene delivery systems Eur. J. Pharm. Biopharm. 60 2005 247 266 (Pubitemid 40804565)
54. J.D. Meyerhoff Effects of alcohol and HIV infection on the central nervous system Alcohol Res. Health 25 2001 288 298
55. R.G. Miller, J.D. Mitchell, and M. Lyon Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) 2007 Vol. CD001447
56. R.H. Müller, and C.M. Keck Drug delivery to the brain-realization by novel drug carriers J. Nanosci. Nanotechnol. 4 2004 471 483 (Pubitemid 39402941)
57. H.B. Newton Advances in strategies to improve drug delivery to brain tumors Expert Rev. Neurother. 6 2006 1495 1509 (Pubitemid 44690919)
58. T. Ogiwara, K. Satoh, Y. Kadoma, Y. Muratami, S. Unten, T. Atsumi, H. Sakagami, and S. Fujisawa Radical scavenging activity and cytotoxicity of ferulic acid Anticancer Res. 22 2002 2711 2717 (Pubitemid 36069302)
59. C. Olbrich, R.H. Müller, and O. Kayser Lipid drug conjugate nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug Diminazene aceturate J. Drug Target. 10 2002 387 396
60. C. Olbrich, A. Gessner, W. Schroder, O. Kayser, and R.H. Muller Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene - Cytotoxicity testing and mouse serum adsorption J. Control. Release 96 2004 425 435 (Pubitemid 38553921)
61. J.F. Oliveira, D.B. Greco, G.C. Oliveira, P.P. Christo, M.D. Guimaraes, and R.C. Oliveira Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: A Brazilian experience Rev. Soc. Bras. Med. Trop. 39 2006 146 151 (Pubitemid 43735881)
62. K. Ono, and M. Yamada Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro Biochem. Biophys. Res. Commun. 336 2005 444 449 (Pubitemid 41267250)
63. W.M. Pardridge Brain drug targeting: The future of brain drug development 2001 Cambridge University Press
64. W.M. Pardridge Why is the global CNS pharmaceutical market so underpenetrated? Drug Discov. Today 7 2002 5 7 (Pubitemid 34093938)
65. W.M. Pardridge Molecular biology of the blood-brain barrier Mol. Biotechnol. 30 2005 57 69 (Pubitemid 41411169)
66. J.H. Park, S. Lee, J.H. Kim, K. Park, K. Kim, and I.C. Kwon Polymeric nanomedicine for cancer therapy Prog. Polym. Sci. 33 2008 113 137 (Pubitemid 350278530)
67. P. Picone, M.L. Bondì, G. Montana, A. Bruno, G. Pitarresi, G. Giammona, and M. Di Carlo Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: Improved delivery by solid lipid nanoparticles Free Radic. Res. 43 2009 1133 1145
68. R.E. Pitas, J.K. Boyles, S.H. Lee, D. Hui, and K.H. Weisgraber Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E, (LDL receptors) in the brain J. Biol. Chem. 262 1987 14352 14560
69. M. Potmesil Camptothecins: From bench research to hospital wards Cancer Res. 54 1994 1431 1439 (Pubitemid 24106402)
70. X. Rabasseda, J. Silvestre, and J. Castañer BMS-232632. Anti-HIV, HIV-1 protease inhibitor Drugs Future 24 1999 375 380 (Pubitemid 29266173)
71. J.S. Reddy, and V. Venkateshwarlu Novel delivery systems for drug targeting to the brain Drugs of Future 29 2004 63 83
72. M. Ricci, P. Blasi, S. Giovagnoli, and C. Rossi Delivering drugs to the central nervous system: A medicinal chemistry or a pharmaceutical technology issue? Curr. Med. Chem. 13 2006 1757 1775 (Pubitemid 43871754)
73. C. Roney, P. Kulkarni, V. Arora, P. Antich, F. Bonte, A. Wu, N.N. Mallikarjuana, S. Manohar, H.F. Liang, A.R. Kulkarni, H.W. Sung, and M. Sairam Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease J. Control. Release 108 2005 193 214 (Pubitemid 41608654)
74. A. Sahu, U. Bora, N. Kasoju, and P. Goswami Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells Acta Biomater. 4 2008 1752 1761
75. B.C. Scott, J. Butler, B. Halliwell, and O.I. Aruoma Evaluation of the antioxidant actions of ferulic acid and catechins Free Radic. Res. Commun. 19 1993 241 253 (Pubitemid 23340481)
76. E.V. Shusta Blood-brain barrier genomics, proteomics, and new transporter discovery NeuroRx 2 2005 151 161 (Pubitemid 40128035)
77. K. Sou, S. Inenaga, S. Takeoka, and E. Tsuchida Loading of curcumin into macrophages using lipid-based nanoparticles Int. J. Pharm. 352 2008 287 293
78. A. Storch, K. Burkhardt, and A.C. Ludolph Protective effects of riluzole on dopamine neurons: Involvement of oxidative stress and cellular energy metabolism J. Neurochem. 75 2000 2259 2269
79. Y. Su, and P.J. Sinko Drug delivery across the blood-brain barrier: Why is it difficult. How to measure and improve it? Expert Opin. Drug Deliv. 3 2006 419 435 (Pubitemid 43772716)
80. S.B. Tiwari, and M.M. Amiji A review of nanocarrier-based CNS delivery systems Curr. Drug Deliv. 3 2006 219 232 (Pubitemid 43738987)
81. T.K. Vyas, A. Shahiwala, S. Marathe, and A. Misra Intranasal drug delivery for brain targeting Curr. Drug Deliv. 2 2006 299 309
82. Z. Wang, Y. Zhang, S. Banerjee, Y. Li, and F.H. Sarkar Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells Cancer 106 2006 2503 2513 (Pubitemid 43787677)
83. S.A. Wissing, O. Kayser, and R.H. Müller Solid lipid nanoparticles for parenteral drug delivery Adv. Drug Deliv. Rev. 56 2004 1257 1272 (Pubitemid 38510473)
84. J.J. Yan, J.Y. Cho, H.S. Kim, K.L. Kim, J.S. Jung, S.O. Huh, H.W. Suh, Y.H. Kim, and D.K. Song Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid Br. J. Pharmacol. 133 2000 89 96
85. S. Yang, J. Zhu, Y. Lu, B. Liang, and C. Yang Body distribution of camptothecin solid lipid nanoparticles after oral administration Pharm. Res. 16 1999 751 757 (Pubitemid 29227107)